Top

Published in:

01-04-2009 | Research Articles

Chemopreventive efficacies of rosiglitazone, fenretinide and their combination against rat mammary carcinogenesis

Authors: Hilal Kocdor, Mehmet Ali Kocdor, Tulay Canda, Duygu Gurel, Ruksan Cehreli, Osman Yilmaz, Mehmet Alakavuklar, Gul Guner

Published in: Clinical and Translational Oncology | Issue 4/2009

Title: Chemopreventive efficacies of rosiglitazone, fenretinide and their combination against rat mammary carcinogenesis
Authors: Hilal Kocdor
Mehmet Ali Kocdor
Tulay Canda
Duygu Gurel
Ruksan Cehreli
Osman Yilmaz
Mehmet Alakavuklar
Gul Guner
Publication date: 01-04-2009
Publisher: Springer Milan
Published in: Clinical and Translational Oncology / Issue 4/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-009-0347-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 4/2009

Synchronous isolated adrenal metastasis from rectum adenocarcinoma

Genetic alterations in chronic lymphocytic leukaemia

Screening practice and misplaced priorities

Pralatrexate, a new hope for aggressive T-cell lymphomas?

Vegetal memory

Peritoneal solitary fibrous tumour (SFT): long-term survival of recurrent and metastasised SFT treated with cytoreductive surgery and intraperitoneal chemotherapy

Keynote webinar | Spotlight on antibody–drug conjugates in cancer